Skip to main content
added 24 characters in body
Source Link
gc5
  • 820
  • 1
  • 7
  • 21

Is there a hierarchy in the setsets of genomic mutations (somatic and germline) to the purpose of treatment in cancer?

Can they be considered at the same level in the context of targeted therapy or are there reasons to prioritise one set vs the other?

Is there a hierarchy in the set of genomic mutations to the purpose of treatment in cancer?

Can they be considered at the same level in the context of targeted therapy or are there reasons to prioritise one set vs the other?

Is there a hierarchy in the sets of genomic mutations (somatic and germline) to the purpose of treatment in cancer?

Can they be considered at the same level in the context of targeted therapy or are there reasons to prioritise one set vs the other?

Source Link
gc5
  • 820
  • 1
  • 7
  • 21

Importance of germline and somatic genomic mutations to the purpose of treatment in cancer

Is there a hierarchy in the set of genomic mutations to the purpose of treatment in cancer?

Can they be considered at the same level in the context of targeted therapy or are there reasons to prioritise one set vs the other?